CNSP

3.5609.07%
AM

Amy Mahery

Independent Director

Ms. Amy Mahery is Independent Director of CNS Pharmaceuticals, Inc. from February 1, 2024. She served as Chief Commercial Officer of Roivant Sciences Ltd. from August 2022. During her tenures at market-leading companies she has been responsible for developing high-impact commercial strategies that delivered profitable growth product portfolios on a global scale. Additionally, in her work at emerging biopharma companies, she has built commercial capabilities from the startup phase to enable the commercialization of first-in-class and best-in-class assets. While working to establish Roivant's commercial operation and capability, enabling profitable growth across the entire portfolio of 10 affiliate Vant companies, she also provides direct commercial leadership to Vants during the start-up phase. Most notably, she served as CCO of Telavant from inception through its sale to Roche. Prior to Roivant, Ms. Mahery held multiple leadership roles at EMD Serono, Inc. (Merck KGaA). Most recently, she served as Senior Vice President and Head of Global Franchise, Neurology and Immunology (N&I) at EMD Serono where she developed and led the implementation of the end-to-end franchise strategy and managed the global P&L for the N&I portfolio. Prior to that, she led worldwide access strategy development across Oncology, Neurology, Immunology, Fertility and General Medicines to create advanced approaches to pricing, reimbursement and patient access as Senior Vice President and Head of Global Market Access and Pricing. Ms. Mahery holds a holds a B.S. in Neuroscience from Trinity College.

Positions